His career began as a veterinarian in Sydney, in the largest practice in Sydney and has always been at the cutting edge of development. He then worked in the UK before completing an MBA in the UK. In 2001 he joined Novartis Animal Health and held various senior sales and marketing positions in Switzerland, US and Australia where he came to fully appreciate the process of drug development, registration, marketing and sales,In 2010, he moved from Pharma to Regenerative Medicine in Regeneus as the Head of Animal Health and then Head of Business Development and Licensing. He saw the company expand from treating dogs and horses with autologous cells to allogeneic treatments of humans, listing on the ASX, and a major licensing deal into Japan.Duncan has since been the CEO of 2 small biotech companies. One of which was folded during COVID, and the other where he oversaw a ten-fold increase in shareholder value.Dr Thomson currently chairs the ARMI Leadership Advisory Board Industry Advisory Committee.